{"title":"Factors Influencing the Efficacy and Safety of Thalidomide in the Treatment of Transfusion-Dependent Thalassaemia","authors":"晓琳 戴","doi":"10.12677/acm.2023.13112388","DOIUrl":null,"url":null,"abstract":"Thalidomide has achieved clinical efficacy as an HbF inducer in the treatment of transfu-sion-dependent thalassaemia (TDT), but concerns have been raised about its side effects of conti-*","PeriodicalId":7237,"journal":{"name":"Advances in Clinical Medicine","volume":"24 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Clinical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12677/acm.2023.13112388","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Thalidomide has achieved clinical efficacy as an HbF inducer in the treatment of transfu-sion-dependent thalassaemia (TDT), but concerns have been raised about its side effects of conti-*